| Howard J Rompre, FNP | |
|
3550 Ne Highway 70 Lot 270, Arcadia, FL 34266-5988 | |
| (941) 661-4683 | |
| Not Available |
| Full Name | Howard J Rompre |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Location | 3550 Ne Highway 70 Lot 270, Arcadia, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992438618 | NPI | - | NPPES |
| Entity Name | Innovative Infusions Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699428490 PECOS PAC ID: 6608054044 Enrollment ID: O20220901002445 |
News Archive
Emerging Healthcare Solutions, Inc. disclosed today that the Company has just favorably completed the financial review phase of due diligence with Stand-By Systems. EHSI recently executed an option with Stand-By Systems; owner of the new FDA approved SBS 1615 catalytic oxygen generator, as well as the associated LIFEDGE® and MAYDAY® emergency systems. EHSI is currently performing due diligence under this option.
The measure, which would keep the federal government functioning until March 18, funds most programs at their current level. It does, however, trim $4 billion by targeting certain programs — but the health law is not "de-funded" in this plan. Still, governors are uneasy about the impact likely federal spending reductions will have on their budgets.
Research presented by P&G Beauty & Grooming scientists at the 68th Annual Meeting of the American Academy of Dermatology (Miami Beach, FL, March 5-9) examines skin care science from multiple perspectives, offering insights into how ingredient formulations, care regimens and gene expressions impact skin condition.
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved a change to the prescribing information for Letairis (ambrisentan 5 mg and 10 mg tablets), the company's once-daily treatment to improve exercise ability and delay clinical worsening in pulmonary arterial hypertension (PAH, WHO Group 1) patients with predominantly WHO Functional Class II-III symptoms.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Howard J Rompre, FNP Po Box 512003, Punta Gorda, FL 33951-2003 Ph: (941) 661-4683 | Howard J Rompre, FNP 3550 Ne Highway 70 Lot 270, Arcadia, FL 34266-5988 Ph: (941) 661-4683 |
News Archive
Emerging Healthcare Solutions, Inc. disclosed today that the Company has just favorably completed the financial review phase of due diligence with Stand-By Systems. EHSI recently executed an option with Stand-By Systems; owner of the new FDA approved SBS 1615 catalytic oxygen generator, as well as the associated LIFEDGE® and MAYDAY® emergency systems. EHSI is currently performing due diligence under this option.
The measure, which would keep the federal government functioning until March 18, funds most programs at their current level. It does, however, trim $4 billion by targeting certain programs — but the health law is not "de-funded" in this plan. Still, governors are uneasy about the impact likely federal spending reductions will have on their budgets.
Research presented by P&G Beauty & Grooming scientists at the 68th Annual Meeting of the American Academy of Dermatology (Miami Beach, FL, March 5-9) examines skin care science from multiple perspectives, offering insights into how ingredient formulations, care regimens and gene expressions impact skin condition.
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved a change to the prescribing information for Letairis (ambrisentan 5 mg and 10 mg tablets), the company's once-daily treatment to improve exercise ability and delay clinical worsening in pulmonary arterial hypertension (PAH, WHO Group 1) patients with predominantly WHO Functional Class II-III symptoms.
› Verified 5 days ago
Jessica Nicole Balok-angelilli, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 725 N 12th Ave Bldg B, Arcadia, FL 34266 Phone: 863-494-1242 Fax: 863-993-0108 | |
Angela Johnson Register, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 725 N 12th Ave Bldg B, Arcadia, FL 34266 Phone: 863-494-1242 Fax: 863-491-0466 | |
Terence Ryan Vereen, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 725 N 12th Ave Bldg B, Arcadia, FL 34266 Phone: 863-494-1242 Fax: 863-491-0466 | |
Kaydean J Vickers, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 725 N 12th Ave Bldg B, Arcadia, FL 34266 Phone: 863-494-1242 | |
Dr. Chandra R Parsley, DNP, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1031 E Oak St, Arcadia, FL 34266 Phone: 863-491-7580 Fax: 863-491-7584 | |
Mr. Douglas Scott Quirk, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 725 N 12th Ave Bldg B, Arcadia, FL 34266 Phone: 863-494-1242 Fax: 863-491-0466 | |
Ms. Cynthia Ann Schackman, ARNP OR PFMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 725 N 12th Ave, Arcadia, FL 34266 Phone: 863-494-1242 Fax: 863-491-0466 |